Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Up 26.2% in April

Aspira Women’s Health Inc. (NASDAQ:AWH) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 169,400 shares, an increase of 26.2% from the March 31st total of 134,200 shares. Approximately 2.5% of the company’s shares are short sold. Based on an average daily volume of 27,900 shares, the days-to-cover ratio is currently 6.1 days.

Analyst Upgrades and Downgrades

Several research firms have commented on AWH. Cantor Fitzgerald restated a “neutral” rating and issued a $3.30 target price on shares of Aspira Women’s Health in a research note on Wednesday, April 10th. StockNews.com started coverage on Aspira Women’s Health in a report on Saturday. They set a “hold” rating on the stock.

Institutional Investors Weigh In On Aspira Women’s Health

Institutional investors and hedge funds have recently made changes to their positions in the stock. Northeast Financial Consultants Inc acquired a new stake in shares of Aspira Women’s Health in the third quarter valued at about $126,000. Perkins Capital Management Inc. acquired a new stake in shares of Aspira Women’s Health in the third quarter valued at about $268,000. Quantum Private Wealth LLC increased its stake in shares of Aspira Women’s Health by 76.8% in the fourth quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock valued at $205,000 after buying an additional 21,788 shares during the period. Finally, B. Riley Wealth Advisors Inc. increased its stake in shares of Aspira Women’s Health by 39.0% in the third quarter. B. Riley Wealth Advisors Inc. now owns 125,374 shares of the company’s stock valued at $672,000 after buying an additional 35,177 shares during the period. Institutional investors and hedge funds own 12.19% of the company’s stock.

Aspira Women’s Health Price Performance

Shares of AWH stock traded up $0.05 on Friday, hitting $3.33. 16,905 shares of the company’s stock were exchanged, compared to its average volume of 22,147. Aspira Women’s Health has a 12 month low of $2.31 and a 12 month high of $6.75. The company has a 50 day moving average of $3.58 and a 200 day moving average of $3.99. The stock has a market cap of $41.05 million, a P/E ratio of -0.28 and a beta of 1.61.

Aspira Women’s Health (NASDAQ:AWH) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.39) by $0.09. The company had revenue of $2.13 million during the quarter, compared to analysts’ expectations of $2.70 million. Aspira Women’s Health had a negative return on equity of 1,099.32% and a negative net margin of 176.74%. Sell-side analysts predict that Aspira Women’s Health will post -1.24 EPS for the current fiscal year.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.